1. Introduction {#sec1-ijerph-16-00106}
===============

Chronic obstructive pulmonary disease (COPD) is predicted to become the fourth leading cause of death worldwide by 2030 \[[@B1-ijerph-16-00106]\]. The most significant cause of COPD, after chronic cigarette smoking, is exposure to biomass smoke, especially in developing countries \[[@B2-ijerph-16-00106]\]. In Asia-Pacific countries and regions, the estimated prevalence of COPD ranges from 3.5% to 6.7% \[[@B3-ijerph-16-00106]\], and the prevalence of COPD in Chiang Dao was 6.8%, which was twice as high as that of Chiang Mai shown in a recent study \[[@B4-ijerph-16-00106]\].

Chiang Dao, with latitude and longitude of 19°21′58′′N 98°57′51′′E, is a district in Chiang Mai Province in Northern Thailand surrounded by high mountain ranges and covering an area of approximately 1882 km^2^. It has a population of around 87,992 people distributed among 7 sub-districts. Due to its geographical features, Chiang Dao has been exposed to air pollution, especially during the dry season, for many years. Agricultural burning and forest fires in Chiang Mai Province has also contributed to the seasonal smog crisis between January and April each year since 2006 \[[@B5-ijerph-16-00106]\].

Particulate matter with particles less than 10 microns in diameter (PM~10~) is a pollutant that is known to adversely affect human health. PM~10~ presents a wide variety of constituents, such as metals and trace elements, organic compounds, and acids \[[@B6-ijerph-16-00106]\]. PM~10~ has been reported to be a significant factor in the exacerbation of respiratory diseases including asthma and COPD \[[@B5-ijerph-16-00106],[@B7-ijerph-16-00106],[@B8-ijerph-16-00106]\]. Previous studies have found that short-term exposure to outdoor air pollution, especially PM~10~, is associated with increased respiratory symptoms \[[@B7-ijerph-16-00106]\], decreased lung function \[[@B8-ijerph-16-00106],[@B9-ijerph-16-00106],[@B10-ijerph-16-00106],[@B11-ijerph-16-00106]\], and acute exacerbation \[[@B5-ijerph-16-00106]\] in COPD patients. However, these studies did not determine the impact of PM~10~ on QoL.

It has been demonstrated that there is a strong relationship between quality of life (QoL) and the number of acute exacerbations of COPD \[[@B12-ijerph-16-00106]\]. To our knowledge, there are limited studies investigating the effects of air pollution on QoL in patients with COPD; however, their results are inconsistent \[[@B13-ijerph-16-00106],[@B14-ijerph-16-00106]\]. The COPD assessment test (CAT) is one of the health-related quality of life (HR-QoL) instruments recently verified for COPD \[[@B15-ijerph-16-00106]\], and the northern Thai version of CAT has already been recommended for the local setting \[[@B16-ijerph-16-00106]\]. However, knowledge regarding the effect of atmospheric air pollution on the QoL of COPD patients determined by the CAT questionnaire is still limited. This study therefore aimed to determine the effect of increased outdoor PM~10~ on QoL and lung function in COPD patients living in the Chiang Dao district of Chiang Mai, Thailand.

2. Materials and Methods {#sec2-ijerph-16-00106}
========================

2.1. Study Design and Population {#sec2dot1-ijerph-16-00106}
--------------------------------

A prospective observational study was conducted between March and August 2016 in Chiang Dao district. Ninety COPD patients were screened for eligibility at the outpatient department of Chiang Dao Hospital, Chiang Mai, Thailand. The recruitment criteria included: patients aged over 40 years with a diagnosis of COPD based on post-bronchodilator (BD) ratio of forced expiratory volume in the first second (FEV~1~)/forced vital capacity (FVC) \<0.7 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria \[[@B17-ijerph-16-00106]\]; ex-smokers with a smoking history of more than 10 pack-years; no history of acute exacerbation (AE) for at least three months prior to the enrollment; and those receiving long term pharmacological treatment for COPD. Patients meeting any of the following criteria were excluded: current diagnosis of asthma; current active respiratory disorders other than COPD, e.g., lung cancer, tuberculosis, or other significant chest X-ray findings not associated with COPD (documented within the past 1 year). Fifty-nine COPD patients were included in this study. The study was approved by the Ethics Committee of the Faculty of Medicine, Chiang Mai University (Study code: MED-2558-03032, Date of approval: 14 December 2015)

2.2. Measurements of Air Pollutants (PM~10~) and Meteorological Parameters {#sec2dot2-ijerph-16-00106}
--------------------------------------------------------------------------

Ambient air concentration of pollutants was measured by Dust DETECT^TM^ at the sampling station located in Chiang Dao hospital, Chiang Mai, Thailand. The analytical method for PM~10~ was specifically designed to monitor the flow of particulate emissions from small stacks and emission points while passing through an air filtration system. The maximum, minimum and daily average of PM~10~ data and meteorological data including temperature, relative humidity, rainfall, wind speed, and pressure were collected for on the months of March and August 2016. The PM~10~ during March was denoted the high PM~10~ period and that during August was denoted the low PM~10~ period. All meteorological data from the monitoring stations in Chiang Dao district is available from <https://meteorology.hrdi.or.th>.

2.3. Outcome Measures {#sec2dot3-ijerph-16-00106}
---------------------

Measurements were collected twice: in March 2016 and in August 2016. Data collection included QoL, dyspnea severity, and post-bronchodilator pulmonary function test.

### 2.3.1. Pulmonary Function Test {#sec2dot3dot1-ijerph-16-00106}

All subjects were evaluated for FVC, FEV~1~, ratio of FEV~1~/FVC and, forced expiratory flow at 25--75% (FEF~25--75%~) using a spirometer (Spiromaster PC-10, CHEST M.I., Inc. Tokyo, Japan) following the standard guidelines recently published by the American Thoracic Society (ATS)/European Respiratory Society (ERS) \[[@B18-ijerph-16-00106]\]. Predicted values were calculated using the Knudson reference equation \[[@B19-ijerph-16-00106]\].

### 2.3.2. Quality of Life and Dyspnea Severity {#sec2dot3dot2-ijerph-16-00106}

The CAT questionnaire, designed to assess the health status of COPD patients, has 8 items covering cough, phlegm, chest tightness, breathlessness when walking up a hill or one flight of stairs, limitation in doing activity, reduced self-confidence, sleep disturbance, and loss of energy. Each item is scored from 0 to 5 to give a total score ranging from 0 to 40, corresponding to the best and worst health status in patients with COPD, respectively \[[@B15-ijerph-16-00106]\]. The northern Thai version of CAT \[[@B16-ijerph-16-00106]\] was administered to all participating subjects. Dyspnea severity was classified using the modified Medical Research Council (mMRC) dyspnea scale \[[@B20-ijerph-16-00106]\].

2.4. Statistical Analysis {#sec2dot4-ijerph-16-00106}
-------------------------

Results for numerical values were expressed as mean ± standard deviation (SD) or median (Interquartile range, IQR) and number (%) for categorical variables. Different values of pollutant data, CAT score, and lung function between low and high PM~10~ periods were determined using paired *t*-tests. A different value of mMRC scores was determined using a Wilcoxon signed rank test. Statistical significance was set at a *p*-value \< 0.05. All analyses were carried out using the SPSS statistical package, version 22 for IBM (IBM Corp., Armonk, NY, USA).

3. Results {#sec3-ijerph-16-00106}
==========

3.1. Patient Characteristics {#sec3dot1-ijerph-16-00106}
----------------------------

Out of 90 patients assessed for eligibility, 31 were excluded due to current diagnosis of asthma (*n* = 14), diagnosis unmet for COPD following GOLD criteria (*n* = 15), and inability to perform spirometry (*n* = 2). The fifty-nine patients meeting the inclusion criteria for enrollment (31 men, 52.5%) had a mean age of 71.5 ± 8.0 years, mean body mass index (BMI) of 20.2 ± 4.1 kg/m^2^, and mean %predicted of FEV~1~ of 64.2 ± 24.3. According to GOLD classification \[[@B17-ijerph-16-00106]\], 13 (22.0%) cases were in GOLD A, 17 (28.8%) in GOLD B, 14 (23.7%) in GOLD C, and 15 (25.4%) in GOLD D categories. All the participants were ex-smokers living in open housing style homes, indicating that they were exposed to atmospheric air 24 h a day. The baseline characteristics of patients in this study are shown in [Table 1](#ijerph-16-00106-t001){ref-type="table"}.

3.2. Pollutant Data {#sec3dot2-ijerph-16-00106}
-------------------

Maximum, minimum, and average PM~10~ were significantly higher in March 2016 (High PM~10~ period) compared to August 2016 (Low PM~10~ period). Atmospheric pressure was also significantly higher during the high PM~10~ period when compared to the low PM~10~ one. In contrast, humidity was significantly lower during the high PM~10~ period compared to the low PM~10~ period. Temperature, rainfall, and wind speed were not statistically different between the high and low PM~10~ periods. The pollutant data are summarized in [Table 2](#ijerph-16-00106-t002){ref-type="table"}.

3.3. Quality of Life and Dyspnea Severity during the High PM~10~ versus the Low PM~10~ Period {#sec3dot3-ijerph-16-00106}
---------------------------------------------------------------------------------------------

Total CAT scores were significantly higher in March 2016 (High PM~10~ period) compared to August 2016 (Low PM~10~ period) (11.7±7.1 vs. 9.6 ± 5.6, *p* = 0.013). In the subdomains of the CAT questionnaire, chest tightness and sleep disturbance were also statistically higher in the high PM~10~ period when compared to the low PM~10~ period (1.2 ± 1.3 vs. 0.7 ± 1.1, *p* = 0.016 and 0.8 ± 1.2 vs. 0.4 ± 0.8, *p* = 0.016 respectively). However, the other subdomains of CAT questionnaire were not statistically different between the high and low PM~10~ periods including the dyspnea severity. The difference in QoL and dyspnea severity between the months of high PM~10~ and low PM~10~ are shown in [Table 3](#ijerph-16-00106-t003){ref-type="table"}.

3.4. Lung Function in the Period of High PM~10~ versus the Period of Low PM~10~ {#sec3dot4-ijerph-16-00106}
-------------------------------------------------------------------------------

FVC and FEV~1~ were significantly lower in March 2016 (High PM~10~ period) when compared to August 2016 (Low PM~10~ period) (2.07 ± 0.68 vs. 2.14 ± 0.68, *p* = 0.025 and 1.19 ± 0.48 vs. 1.25 ± 0.51, *p* = 0.008 respectively). However, there was no statistically significant difference in FEF~25--75%~ data between March 2016 (High PM~10~ period) and August 2016 (Low PM~10~ period). The differences in lung function between the months of high PM~10~ versus low PM~10~ are shown in [Table 4](#ijerph-16-00106-t004){ref-type="table"}.

4. Discussion {#sec4-ijerph-16-00106}
=============

The observational study conducted in Chiang Mai, Thailand, revealed poor QoL, particularly in the form of chest tightness and sleep disturbance as well as a decreased lung function during the high PM~10~ period in patients with COPD. The latter was supported by previously published studies where decrements in both FVC and FEV~1~ were associated with increasing pollution concentration in patients with COPD \[[@B9-ijerph-16-00106],[@B10-ijerph-16-00106]\]. Our results on the decrease in FEV~1~ of about 60 milliliters between the high and low PM~10~ period was twice that of an earlier study which reported a 30 milliliters/year decline in FEV~1~ \[[@B21-ijerph-16-00106]\]. In our study, the FEF~25--75%~ did not show a statistically significant decrease during the high PM~10~ period, which probably reflects the impact of a chronic disease, as subjects with COPD may have difficulty with this effort-dependent maneuver. Therefore, in these subjects, FEV~1~ appears to be a more robust parameter than small airway function tests. Additionally, FEF~25--75%~ is dependent on the FVC, and therefore, changes in FVC will affect the portion of the flow-volume curve examined. If FEF~25--75%~ is not adjusted for lung volume, there is poor reproducibility \[[@B22-ijerph-16-00106]\].

There was a significant decrease in QoL when measured by total CAT score during the high PM~10~ period, especially in the form of chest tightness and sleep disturbance subdomains. However, there were no significant increases in cough, phlegm, and physical activity limitation associated with PM~10~ in our study, in contrast to previous reports \[[@B7-ijerph-16-00106],[@B23-ijerph-16-00106],[@B24-ijerph-16-00106]\].

The exact mechanism by which PM~10~ may influence lung function is uncertain \[[@B25-ijerph-16-00106]\]. However, previous studies suggest that PM~10~ may mediate adverse health effects via the generation of reactive oxygen species (ROS), activation of cell signaling pathways, and alterations of respiratory tract barrier function and antioxidant defenses, all of which may lead to airway inflammation and changes in pulmonary function \[[@B26-ijerph-16-00106],[@B27-ijerph-16-00106],[@B28-ijerph-16-00106]\]. In cases of COPD, these factors could explain the activation of inflammatory mechanisms causing tissue damage and subsequently increasing the sensitivity of the trachea leading to the decrements in lung function. In addition, a previous review on the role of PM~10~ as a cause of oxidative stress enhancing pro-inflammatory effects in the airway of patients already activated by the disease \[[@B29-ijerph-16-00106]\], might explain the aggravation of symptoms in patients with COPD, specifically chest tightness and sleep disturbances.

The major strength of our study was that we selected a very specific population of COPD, therefore limiting extraneous variables as much as possible. The population included Chiang Dao dwellers living in areas exposed to seasonal smog during the entire study period. All of them were ex-smokers and were exposed to atmospheric air pollution at all times. However, our study has several limitations. Firstly, a time series analysis to assess the trends and relationships using generalized estimation equation with Poisson regression analysis could not be executed due to the nature of the data collected. Secondly, the other pollutants, including SO~2~, NO~2~, CO, and O~3~, as well as the temperature and humidity, could not be adjusted. Thirdly, the influence of other pollutants, including SO~2~, NO~2~, CO, and O~3~, or other metrological data, on QoL and lung function could not be demonstrated due to limited data.

5. Conclusions {#sec5-ijerph-16-00106}
==============

This study suggests that there is a short-term negative impact of exposure to PM~10~ on QoL and lung function in patients with COPD. Worsening of QoL, particularly chest tightness and sleep disturbance and decrements in lung function (FVC and FEV~1~), were shown during the high PM~10~ period. These results might provide useful information for improving the health of COPD patients during periods of high air pollution.
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###### 

Baseline characteristics of patients in this study.

  Variables                      All Patients (*n* = 59)
  ------------------------------ -------------------------
  Age (years)                    71.5 ± 8.0
  Male sex, *n* (%)              31 (52.5)
  BMI (kg/m^2^)                  20.2 ± 4.1
  Smoking pack-year              36.0 ± 38.8
  Pulmonary function data        
   FVC                           2.07 ± 0.68
   Percent predicted of FVC      89.0 ± 25.9
   FEV~1~                        1.19 ± 0.48
   Percent predicted of FEV~1~   64.2 ± 24.3
   Ratio of FEV~1~/FVC (%)       57.0 ± 10.2
  GOLD classification, N (%)     
   A                             13 (22.0)
   B                             17 (28.8)
   C                             14 (23.7)
   D                             15 (25.4)
  Hx. of AECOPD                  16 (27.1)
  No. of AECOPD (pt/year)        2.4 ± 2.5
  Charlson comorbidity index     3.86 ± 1.04
  Medication used                
   SABA                          42 (71.2)
   Oral beta-2 agonist           32 (54.2)
  LTOT                           1 (1.7)
  Ex-smoker                      59 (100.0)
  Open-housing style             59 (100.0)

**Notes:** Results are expressed as mean ± SD; GOLD A was defined as low symptom severity and low exacerbation risk; GOLD B was defined as high symptom severity and low exacerbation risk; GOLD C was defined as low symptom severity and high exacerbation risk; GOLD D was defined as high symptom severity high exacerbation risk; low symptom severity is considered a CAT score less than or equal to 9, high symptom severity is considered a CAT ≥ 10; low risk of exacerbation is defined as no more than one exacerbation not resulting in hospital admission in the last 12 months; high risk of exacerbation is defined as at least two exacerbations or any exacerbations resulting in hospital admission in the last 12 months. **Abbreviations:** BMI, Body mass index; FVC, forced vital capacity, FEV~1~, forced expiratory volume in first second; AECOPD, acute exacerbation of COPD; SABA, short acting beta-2 agonist; LTOT, long term oxygen therapy.
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###### 

Pollutant data between the high PM~10~ period (March 2016) and the low PM~10~ period (August 2016).

  Variables                      Low PM~10~ (August 2016)   High PM~10~ (March 2016)   *p*-Value
  ------------------------------ -------------------------- -------------------------- -----------
  PM~10~ (µg/m^3^) Max (range)   40.9 (31.3--45.4)          215.8 (149.1--268.5)       0.001
  PM~10~ (µg/m^3^) Min (range)   13.3 (10.5--24.3)          51.7 (28.1--80.8)          0.034
  PM~10~ (µg/m^3^) Mean(range)   29.2 (18.4--32.4)          120.4 (82.3--149.2)        0.003
  Temperature (°C)               25.8 (25.4--26.1)          25.8 (24.1--26.4)          0.248
  Rainfall (mm)                  0.0 (0.0--0.0)             0.0 (0.0--0.0)             0.076
  Wind speed (km/h)              33.4 (20.4--51.9)          37.1 (31.5--40.8)          0.800
  Humidity (%)                   67.5 (66.8--68.3)          61.8 (61.2--62.2)          \<0.001
  Pressure (millibar)            1004.5 (1002.9--1006.7)    1014.8 (1021.1--1015.3)    0.028

**Note:** Data are median (IQR); **Abbreviations:** IQR, interquartile range; PM~10~, Particulate matters with diameter of less than 10 micron; m^3^, per cubic meter.
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###### 

Quality of life and dyspnea in the period of high PM~10~ versus the period of low PM~10~.

  Variables                                       Low PM~10~   High PM~10~   *p*-Value
  ----------------------------------------------- ------------ ------------- -----------
  CAT total score                                 9.6 ± 5.6    11.7 ± 7.1    0.013 \*
   Cough                                          1.6 ± 1.0    1.7 ± 1.0     0.756
   Phlegm                                         1.4 ± 1.2    1.5 ± 1.2     0.492
   Chest tightness                                0.7 ± 1.1    1.2 ± 1.3     0.016 \*
   Breathless when walk up a hill or one flight   1.6 ± 1.2    1.8 ± 1.4     0.395
   Limit doing activity                           1.1 ± 1.2    1.5 ± 1.3     0.098
   Self confidence                                1.0 ± 1.3    1.3 ± 1.7     0.379
   Sleep disturbance                              0.4 ± 0.8    0.8 ± 1.2     0.016 \*
   Loss of energy                                 1.8 ± 1.2    2.0 ± 1.2     0.370
  mMRC (median, IQR)                              1 (1--2)     1 (1--3)      0.465

**Notes:** Results are expressed as mean ± SD or median (IQR); \*, statistical significance. **Abbreviations:** CAT, COPD assessment test; mMRC, modified medical research council score
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###### 

Lung function in the period of high PM~10~ versus the period of low PM~10~.

  Lung Function Data   Low PM~10~    High PM~10~   *p*-Value
  -------------------- ------------- ------------- -----------
  FVC (L)              2.14 ± 0.68   2.07 ± 0.68   0.025 \*
  FEV~1~ (L)           1.25 ± 0.51   1.19 ± 0.48   0.008 \*
  FEF~25--75%~ (L)     0.64 ± 0.38   0.59 ± 0.31   0.122

**Notes:** Results are expressed as mean ± SD; \*, statistically significant. **Abbreviations:** FVC, forced vital capacity; FEV~1~, forced expiratory volume in first second; FEF~25--75%~, forced expiratory flow at 25--75% of FVC.
